MENU
SAGE
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Sage Therapeutics (SAGE) Ownership - Who owns Sage Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
445.06M
P/E Ratio
N/A
Total Cash
646.79M
Projected Growth
N/A
Total Debt
1.41M
Revenue
97.24M
Risk (Beta)
0.28
Dividend Yield
N/A
Total Cash/Share
10.59
Total Debt/Equity
N/A
Revenue/Share
1.62 USD as % of share price
Fundamentals
SAGE
Capitalization
445M
P/E Ratio
N/A
Risk (Beta)
0.28
Dividend Yield
N/A
Total Cash
647M
Total Cash/Share
10.59
Total Debt
1.41M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.62%
Revenue
97.2M
ROE
N/A
Book Value
628M
P/B Ratio
0.70
Cash Flow
N/A
Earnings
-7.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
9.95
Current Revenue Per Employee
17770.02
Dividends Per Share - Security
N/A
EBITDA
-448.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.74
Revenue To Assets
-50.09
Shares Held By Institutions
2.02B
Shares Outstanding - Current
61.1M
Total Liabilities
69M
Total Volume MTD
N/A
Value
1
Gain YTD
-66.451
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics and medicines for central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com